{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:33:15Z","timestamp":1790695995603,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,11,17]],"date-time":"2009-11-17T00:00:00Z","timestamp":1258416000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00277-009-0861-0","type":"journal-article","created":{"date-parts":[[2009,11,16]],"date-time":"2009-11-16T07:40:15Z","timestamp":1258357215000},"page":"535-544","source":"Crossref","is-referenced-by-count":14,"title":["Cytogenetic features and prognosis analysis in Chinese patients with myelodysplastic syndrome: a multicenter study"],"prefix":"10.1007","volume":"89","author":[{"given":"Hong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoQin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoPing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GuoWei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,17]]},"reference":[{"key":"861_CR1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189\u2013199","journal-title":"Br J Haematol"},{"key":"861_CR2","first-page":"20","volume":"10","author":"S Rosati","year":"1996","unstructured":"Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW (1996) Refractory cytopenia with multilineage dysplasia: further characterization of an \u2018unclassifiable\u2019 myelodysplastic syndrome. Leukemia 10:20\u201326","journal-title":"Leukemia"},{"key":"861_CR3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10428199309148501","volume":"9","author":"JL Michaux","year":"1993","unstructured":"Michaux JL, Martiat P (1993) Chronic myelomonocytic leukaemia (CMML)\u2014a myelodysplastic or myeloproliferative syndrome? Leuk Lymphoma 9:35\u201341","journal-title":"Leuk Lymphoma"},{"key":"861_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF01696227","volume":"71","author":"GE Verhoef","year":"1995","unstructured":"Verhoef GE, Pittaluga S, De Wolf-Peeters C, Boogaerts MA (1995) FAB classification of myelodysplastic syndromes: merits and controversies. Ann Hematol 71:3\u201311","journal-title":"Ann Hematol"},{"key":"861_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2141.1985.tb07329.x","volume":"59","author":"GJ Mufti","year":"1985","unstructured":"Mufti GJ, Stevens JR, Oscier DG, Hamblin TJ, Machin D (1985) Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 59:425\u2013433","journal-title":"Br J Haematol"},{"key":"861_CR6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1182\/blood.V74.1.395.395","volume":"74","author":"GF Sanz","year":"1989","unstructured":"Sanz GF, Sanz MA, Vallespi T, Canizo MC, Torrabadella M, Garcia S, Irriguible D, San Miguel JF (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 74:395\u2013408","journal-title":"Blood"},{"key":"861_CR7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0145-2126(90)90133-T","volume":"14","author":"JE Goasguen","year":"1990","unstructured":"Goasguen JE, Garand R, Bizet M, Bremond JL, Gardais J, Callat MP, Accard F, Chaperon J (1990) Prognostic factors of myelodysplastic syndromes\u2014a simplified 3-D scoring system. Leuk Res 14:255\u2013262","journal-title":"Leuk Res"},{"key":"861_CR8","first-page":"1315","volume":"7","author":"P Morel","year":"1993","unstructured":"Morel P, Hebbar M, Lai JL, Duhamel A, Preudhomme C, Wattel E, Bauters F, Fenaux P (1993) Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 7:1315\u20131323","journal-title":"Leukemia"},{"key":"861_CR9","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89:2079\u20132088","journal-title":"Blood"},{"key":"861_CR10","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","volume":"100","author":"JW Vardiman","year":"2002","unstructured":"Vardiman JW, Harris NL, Brunning RD (2002) The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100:2292\u20132302","journal-title":"Blood"},{"key":"861_CR11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0145-2126(00)00088-6","volume":"24","author":"U Germing","year":"2000","unstructured":"Germing U, Gattermann N, Strupp C, Aivado M, Aul C (2000) Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leuk Res 24:983\u2013992","journal-title":"Leuk Res"},{"key":"861_CR12","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1182\/blood.V98.10.2935","volume":"98","author":"T Nosslinger","year":"2001","unstructured":"Nosslinger T, Reisner R, Koller E, Gruner H, Tuchler H, Nowotny H, Pittermann E, Pfeilstocker M (2001) Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution. Blood 98:2935\u20132941","journal-title":"Blood"},{"key":"861_CR13","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1182\/blood-2003-06-2124","volume":"103","author":"RB Howe","year":"2004","unstructured":"Howe RB, Porwit-MacDonald A, Wanat R, Tehranchi R, Hellstrom-Lindberg E (2004) The WHO classification of MDS does make a difference. Blood 103:3265\u20133270","journal-title":"Blood"},{"key":"861_CR14","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.1200\/JCO.2005.01.7038","volume":"23","author":"L Malcovati","year":"2005","unstructured":"Malcovati L, Porta MG, Pascutto C, Invernizzi R, Boni M, Travaglino E, Passamonti F, Arcaini L, Maffioli M, Bernasconi P, Lazzarino M, Cazzola M (2005) Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. J Clin Oncol 23:7594\u20137603","journal-title":"J Clin Oncol"},{"key":"861_CR15","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1182\/blood-2005-01-0040","volume":"106","author":"A Matsuda","year":"2005","unstructured":"Matsuda A, Germing U, Jinnai I, Misumi M, Kuendgen A, Knipp S, Aivado M, Iwanaga M, Miyazaki Y, Tsushima H, Sakai M, Bessho M, Tomonaga M (2005) Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes. Blood 106:2633\u20132640","journal-title":"Blood"},{"key":"861_CR16","first-page":"1596","volume":"91","author":"U Germing","year":"2006","unstructured":"Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B, Giagounidis A, Aul C, Gattermann N, Haas R (2006) Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Haematologica 91:1596\u20131604","journal-title":"Haematologica"},{"key":"861_CR17","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2006.08.5696","volume":"25","author":"L Malcovati","year":"2007","unstructured":"Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, Invernizzi R, Giagounidis A, Hildebrandt B, Bernasconi P, Knipp S, Strupp C, Lazzarino M, Aul C, Cazzola M (2007) Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol 25:3503\u20133510","journal-title":"J Clin Oncol"},{"key":"861_CR18","unstructured":"Mitelman FKS, Basal (1995) An International System for Human Cytogenetic Nomenclature."},{"key":"861_CR19","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1182\/blood.V63.6.1318.1318","volume":"63","author":"WH Raskind","year":"1984","unstructured":"Raskind WH, Tirumali N, Jacobson R, Singer J, Fialkow PJ (1984) Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood 63:1318\u20131323","journal-title":"Blood"},{"key":"861_CR20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.leu.2402798","volume":"17","author":"JH Lee","year":"2003","unstructured":"Lee JH, Shin YR, Lee JS, Kim WK, Chi HS, Park CJ, Seo EJ, Lee KH (2003) Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome. Leukemia 17:305\u2013313","journal-title":"Leukemia"},{"key":"861_CR21","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/cncr.22570","volume":"109","author":"X Ma","year":"2007","unstructured":"Ma X, Does M, Raza A, Mayne ST (2007) Myelodysplastic syndromes: incidence and survival in the United States. Cancer 109:1536\u20131542","journal-title":"Cancer"},{"key":"861_CR22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.leu.2403688","volume":"19","author":"B Chen","year":"2005","unstructured":"Chen B, Zhao WL, Jin J, Xue YQ, Cheng X, Chen XT, Cui J, Chen ZM, Cao Q, Yang G, Yao Y, Xia HL, Tong JH, Li JM, Chen J, Xiong SM, Shen ZX, Waxman S, Chen Z, Chen SJ (2005) Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries. Leukemia 19:767\u2013775","journal-title":"Leukemia"},{"key":"861_CR23","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1002\/cncr.23977","volume":"113","author":"O Pozdnyakova","year":"2008","unstructured":"Pozdnyakova O, Miron PM, Tang G, Walter O, Raza A, Woda B, Wang SA (2008) Cytogenetic abnormalities in a series of 1, 029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities. Cancer 113:3331\u20133340","journal-title":"Cancer"},{"key":"861_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2141.2007.06537.x","volume":"137","author":"P Bernasconi","year":"2007","unstructured":"Bernasconi P, Klersy C, Boni M, Cavigliano PM, Calatroni S, Giardini I, Rocca B, Zappatore R, Caresana M, Dambruoso I, Lazzarino M, Bernasconi C (2007) World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. Br J Haematol 137:193\u2013205","journal-title":"Br J Haematol"},{"key":"861_CR25","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0145-2126(94)00135-W","volume":"19","author":"S Oguma","year":"1995","unstructured":"Oguma S, Yoshida Y, Uchino H, Maekawa T, Nomura T, Mizoguchi H (1995) Clinical characteristics of Japanese patients with primary myelodysplastic syndromes: a co-operative study based on 838 cases. Anemia Study Group of the Ministry of Health and Welfare. Leuk Res 19:219\u2013225","journal-title":"Leuk Res"},{"key":"861_CR26","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2141.2004.04860.x","volume":"124","author":"GB Tennant","year":"2004","unstructured":"Tennant GB, Cavill I, Burnett AK (2004) Long-term survival of myelodysplastic patients with macrocytosis. Br J Haematol 124:840\u2013841","journal-title":"Br J Haematol"},{"key":"861_CR27","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/ajh.21245","volume":"83","author":"SG Holtan","year":"2008","unstructured":"Holtan SG, Santana-Davila R, Dewald GW, Khetterling RP, Knudson RA, Hoyer JD, Chen D, Hanson CA, Porrata L, Tefferi A, Steensma DP (2008) Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era. Am J Hematol 83:708\u2013713","journal-title":"Am J Hematol"},{"key":"861_CR28","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.leukres.2008.10.009","volume":"33","author":"J Bjork","year":"2009","unstructured":"Bjork J, Johansson B, Broberg K, Albin M (2009) Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: a case-control study. Leuk Res 33:788\u2013791","journal-title":"Leuk Res"},{"key":"861_CR29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001648-200005000-00010","volume":"11","author":"J Bjork","year":"2000","unstructured":"Bjork J, Albin M, Mauritzson N, Stromberg U, Johansson B, Hagmar L (2000) Smoking and myelodysplastic syndromes. Epidemiology 11:285\u2013291","journal-title":"Epidemiology"},{"key":"861_CR30","volume-title":"World health organization classification of tumours. Pathology & genetics tumours of haematopoietic and lymphoid tissues","author":"RD Brunning","year":"2008","unstructured":"Brunning RD, Orazi A, Germing U et al (2008) World health organization classification of tumours. Pathology & genetics tumours of haematopoietic and lymphoid tissues. IARC, Lyon"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0861-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-009-0861-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-009-0861-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T17:32:23Z","timestamp":1590255143000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-009-0861-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,17]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1007\/s00277-009-0861-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,17]]}}}